GELS
Gelteq Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.43
−3.50%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.45
From 52W high−71.87%
Volume190276.00
Market cap$4.81M
P/E (TTM)—
P/S (TTM)24.7x
Div yield—
Key dataOct 19, 2026
Open
$0.45
From 52W high
−71.87%
Volume
190276.00
Market cap
$4.81M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
P/E (TTM)
—
RSI (14)
35.1
MomentumView details →
1D Return
−3.50%
YTD Return
−46.13%
SummaryUpdated Dec 1, 2025
Gelteq Limited (NASDAQ:GELS) is an Australian pharmaceutical technology company founded in 2017 and headquartered in Caulfield, Australia. The company specializes in developing and commercializing innovative gel-based delivery systems for pharmaceutical and consumer health products across both human and animal applications. Since its incorporation, Gelteq has positioned itself as a white-label solutions provider in the drug delivery space, focusing on creating proprietary gel formulations that can enhance the effectiveness and user experience of various therapeutic and wellness products.
Similar companies
Latest newsMore news →